Skip to content

Public title:A study on the clinical analgesic effect and safety of sub-anesthetic dose esketamine combined with opioids in elderly patients under general anesthesia

Public title:A study on the clinical analgesic effect and safety of sub-anesthetic dose esketamine combined with opioids in elderly patients under general anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116419
Enrollment
Unknown
Registered
2026-01-09
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia for elderly patients

Interventions

experimental group:In the experimental group, esketamine at a dose of 0.25 mg/kg was intravenously injected during the general anesthesia induction, and then 0.1 mg/(kg·h) of esketamine was continuous
Control group:Use an equal volume of normal saline instead of esketamine, with all other medications and anesthesia protocols the same as the experimental group (Esk group).

Sponsors

Henan Provincial Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 Age >= 65 years old, able to tolerate general anesthesia and surgery, and willing to undergo at least 1-year follow-up; 2 Body mass index between 18 - 30 kg/m^2; 3 American Society of Anesthesiologists (ASA) classification of grades I - III.

Exclusion criteria

Exclusion criteria: 1 Uncontrolled severe systemic diseases (such as severe cardiovascular and cerebrovascular diseases, infections, coagulation disorders, etc.); 2 Cognitive dysfunction, mental illness or a history of delirium before the surgery, which affects the postoperative assessment; 3 Severe liver or kidney dysfunction; 4 Alcohol or drug dependence; 5 Allergic to the drugs used in this study.

Design outcomes

Primary

MeasureTime frame
Postoperative VAS pain score, total dosage of sufentanil used;Total dosage of sufentanil used;

Secondary

MeasureTime frame
Postoperative sleep score;The incidence rates of adverse reactions such as postoperative nausea, vomiting, dizziness, and hallucinations;

Countries

China

Contacts

Public ContactAn Jing

Henan Provincial Third People's Hospital

52823552@qq.com+86 135 2656 0188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026